CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,705,600 | +41.9% | 280,000 | +75.0% | 1.40% | +65.4% |
| Q2 2023 | $5,428,800 | -15.8% | 160,000 | -4.1% | 0.85% | +19.8% |
| Q4 2021 | $6,444,000 | -8.4% | 166,766 | +28.0% | 0.71% | +19.8% |
| Q3 2021 | $7,037,000 | +55.0% | 130,330 | -40.8% | 0.59% | +69.8% |
| Q1 2021 | $4,539,000 | -56.6% | 220,320 | -63.1% | 0.35% | -62.5% |
| Q4 2020 | $10,463,000 | +90.7% | 597,198 | +61.4% | 0.93% | +72.4% |
| Q3 2020 | $5,487,000 | – | 370,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
| Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
| TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
| ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
| 5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
| COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
| RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
| Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
| Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
| Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |